Skip to main content
Equibles

Swiss National Bank

Bank

Position in NVCR — NovoCure Ltd

CIK 1582202 ZURICH, V8
Back to NVCR Full portfolio

Position in NVCR

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$3,113,325
+$829,775 QoQ
Shares Held
205,500
-1.9% QoQ
Ownership
0.176%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 217 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVCR Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $1,824,819,495 across 41 Medical Devices names. NVCR ranks #26 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 4,912,380 $445,749,361
2 SYK
Stryker Corp
 972,180 $306,081,151
3 MDT
Medtronic plc
 3,621,066 $283,275,993
4 BSX
Boston Scientific Corp
 4,191,800 $178,906,024
5 EW
Edwards Lifesciences Corp
 1,626,100 $147,097,006
6 GEHC
GE HealthCare Technologies Inc.
 1,286,887 $82,373,636
7 DXCM
Dexcom Inc
 1,085,500 $73,108,425
8 STE
STERIS plc
 276,560 $58,235,239

All Filings in NVCR

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,113,325 205,500
2026-03-31 $2,283,550 209,500
2025-12-31 $2,708,835 209,500
2025-09-30 $2,652,476 205,300
2025-06-30 $3,543,980 199,100
2025-03-31 $3,547,962 199,100
2024-12-31 $6,025,560 202,200
2024-09-30 $3,119,748 199,600
2024-06-30 $3,419,148 199,600
2024-03-31 $3,119,748 199,600
2023-12-31 $2,980,028 199,600
2023-09-30 $3,578,840 221,600
2023-06-30 $14,163,950 341,300
2023-03-31 $22,486,346 373,900
2022-12-31 $28,100,385 383,100
2022-09-30 $30,927,507 407,048
2022-06-30 $28,310,686 407,348
2022-03-31 $33,533,371 404,748
2021-12-31 $26,611,955 354,448
2021-09-30 $42,756,136 368,048
2021-06-30 $83,370,603 375,848
2021-03-31 $43,989,504 332,800
2020-12-31 $56,151,480 324,500
2020-09-30 $21,538,485 193,500
2020-06-30 $11,213,630 189,100
2020-03-31 $10,343,424 153,600